Medicines and Healthcare products Regulatory Agency
| 1: Authorisation Number | UK MIA 60304 | 
|---|---|
| 2: Name of authorisation holder | MODERNA BIOTECH MANUFACTURING UK LTD | 
| 3: Address(es) of manufacturing site(s) | MODERNA TECHNOLOGY CENTRE - HARWELL (MTC-H), PERIMETER ROAD, HARWELL OXFORD, DIDCOT, OX11 0GN, UNITED KINGDOM | 
| 4: Legally registered address of authorisation holder | MODERNA BIOTECH MANUFACTURING UK LTD, 54 PORTLAND PLACE, LONDON, W1B 1DY, UNITED KINGDOM | 
| 5: Scope of authorisation and dosage forms | ANNEX 1 and/ or ANNEX 2 | 
| 6: Legal Basis of authorisation | |
| 7: Name of responsible officer of the competent authority of the member state granting the manufacturing authorisation | Confidential | 
| 8: Authorisation Date | 19/06/2025 | 
| 9: Annexes attached | Annex 1 and/or Annex 2 | 
SCOPE OF AUTHORISATION
        Annex 1
        
          Name and address of the site: 
          
      
              
          
  
        
        
        MODERNA TECHNOLOGY CENTRE - HARWELL (MTC-H), PERIMETER ROAD, HARWELL OXFORD, DIDCOT, OX11 0GN, UNITED KINGDOM
                                Human Medicinal Products
                            
      | Authorised Operations | 
| MANUFACTURING OPERATIONS (according to part 1) | 
| Part 1 - MANUFACTURING OPERATIONS | 
| [ 1.1 ] Sterile Products | 
| [ 1.1.3 ] Batch certification | 
| [ 1.3 ] Biological medicinal products | 
| [ 1.3.1 ] Biological medicinal products | 
| [ 1.3.1.2 ]  Immunological products Special Requirements Manf. of low bioburden drug substance (mRNA) and low bioburden Intermediates (mRNA Lipid Nanoparticle (LNP)) products | 
| [ 1.3.1.5 ] Biotechnology products Special Requirements Manf. of low bioburden drug substance (mRNA) and low bioburden Intermediates (mRNA Lipid Nanoparticle (LNP)) products | 
| [ 1.3.2 ] Batch certification | 
| [ 1.3.2.2 ] Immunological products Special Requirements Manf. of low bioburden drug substance (mRNA) and low bioburden Intermediates (mRNA Lipid Nanoparticle (LNP)) products | 
| [ 1.3.2.5 ] Biotechnology products Special Requirements Manf. of low bioburden drug substance (mRNA) and low bioburden Intermediates (mRNA Lipid Nanoparticle (LNP)) products | 
| [ 1.6 ] Quality control testing | 
| [ 1.6.3 ] Chemical/Physical | 
| [ 1.6.4 ] Biological | 
